Diabetes Care 27:2568-2569, 2004
© 2004 by the American Diabetes Association, Inc.
Letters: Comments and Responses |
Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030
Response to Wild et al.
Wolfgang Rathmann, MD, MSPH and
Guido Giani, PHD
From the Department of Biometrics and Epidemiology, German Diabetes Research Institute, Heinrich Heine University, Düsseldorf, Germany
Address correspondence to Dr. Wolfgang Rathmann, MD, MSPH, German Diabetes Research Institute, Aufm Hennekamp 65, D-40225 Düsseldorf, Germany. E-mail: rathmann{at}ddfi.uni-duesseldorf.de
Global diabetes prevalence estimates for adults in 2000, which were derived from population-based data using oral glucose tolerance tests, were recently reported by Wild et al. (1). Because there are few OGTT-based data in the European region, estimates from a regional study carried out in the Netherlands were applied to 13 other countries, including Germany (2). For Germany, a prevalence of 4.1% was estimated, which corresponds to 2.6 million people with diabetes in 2000 (1).
In the German National Health Interview and Examination Survey in 1998, prevalence of known diabetes (self-reported) was assessed in a representative sample (aged 1879 years) (3). Furthermore, from 1999 to 2001, glucose tolerance tests were carried out in the population-based KORA Survey 2000 (Augsburg, Germany) among 1,353 subjects aged 5574 years (4). Both provided higher age- and sex-specific prevalence estimates than the Dutch study (2). Thus, 5% of the adult German population had known diabetes in 1998. In addition, at least in the age-group >55 years, one-half of the total cases were undiagnosed (4). The total diabetes prevalence (diagnosed and undetected cases) in the 55- to 74-year age-group was 16.6% in the KORA Survey (4). As the one-for-one ratio for known/undiagnosed case subjects is valid for all age-groups, the total diabetes prevalence in the adult German population in 2000 was 10%, corresponding to 6.3 million people. Germany should be listed among the 10 countries with the highest estimated number of people with diabetes in the world (1).
Thus, there is a greater diversity of diabetes prevalence in European countries than suggested by Wild et al. There are also differences in known risk factors for type 2 diabetes at the population level in European countries, e.g., the prevalence of obesity in Germany (20%) was almost twofold higher than in the Netherlands (5). Furthermore, the percentage of persons who did not partake in physical activity during their leisure time was higher in Germany (22.6%) than in the Netherlands (14.4%) and other European countries, which may partly explain the wide variation of diabetes prevalence (6).
References
- Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care27:10471053, 2004[Abstract/Free Full Text]
- Mooy JM, Grootenhuis PA, de Vries H, Valkenburg HA, Bouter LM, Kostense PJ, Heine RJ: Prevalence and determinants of glucose intolerance in a Dutch Caucasian population: the Hoorn Study. Diabetes Care 18:12701273, 1995[Abstract]
- Thefeld W: Prevalence of diabetes mellitus in the adult population in Germany [in German]. Gesundheitswesen 61 (Suppl. 2):S85S89, 1999
- Rathmann W, Haastert B, Icks A, Löwel H, Meisinger C, Holle R, Giani G: High prevalence of undiagnosed diabetes mellitus in southern Germany: target populations for efficient screening: the KORA Survey 2000. Diabetologia46:182189, 2003[Medline]
- Seidell JC: Obesity in Europe: scaling an epidemic. Int J Obes Relat Metab Disord 19 (Suppl. 3):S1S4, 1995
- Varo JJ, Martinez-Gonzalez MA, Irala-Estevez J, Kearney J, Gibney M, Martinez JA: Distribution and determinants of sedentary lifestyles in the European Union. Int J Epidemiol 32:138146, 2003[Abstract/Free Full Text]

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Yang, J. Wang, Y. Chen, Z. Sun, R. Wang, and Y. Dai
Effect of Caffeine on Erectile Function via Up-Regulating Cavernous Cyclic Guanosine Monophosphate in Diabetic Rats
J Androl,
September 1, 2008;
29(5):
586 - 591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Baumann, D. Blobner, T. Van Binh, and P. T. Lan
A training program for diabetes care in Vietnam.
The Diabetes Educator,
March 1, 2006;
32(2):
189 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Roglic, N. Unwin, P. H. Bennett, C. Mathers, J. Tuomilehto, S. Nag, V. Connolly, and H. King
The Burden of Mortality Attributable to Diabetes: Realistic estimates for the year 2000
Diabetes Care,
September 1, 2005;
28(9):
2130 - 2135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Wild, G. Roglic, A. Green, R. Sicree, and H. King
Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030: Response to Rathman and Giani
Diabetes Care,
October 1, 2004;
27(10):
2569 - 2570.
[Full Text]
[PDF]
|
 |
|
|
|
|